MAPK3 and prostate carcinoma: CD74 was found to be overexpressed in prostate cancer cell DU145, as compared with normal prostate cells, and blocking interaction of MIF with CD74 selectively inactivated ERK1/2, leading to reduced prostate cancer cell proliferation and increased apoptosis [48].